Crossject Société Anonyme (EPA:ALCJ)
1.582
+0.082 (5.47%)
Aug 3, 2026, 12:39 PM CET
Crossject Société Anonyme Revenue
In the year 2025, Crossject Société Anonyme had annual revenue of 14.88M EUR with 12.24% growth. Crossject Société Anonyme had revenue of 1.37M in the half year ending December 31, 2025, a decrease of -71.89%.
Revenue
14.88M
Revenue Growth
+12.24%
P/S Ratio
31.80
Revenue / Employee
25.94K
Employees
99
Market Cap
81.67M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 14.88M | 1.62M | 12.24% |
| Dec 31, 2024 | 13.26M | -68.00K | -0.51% |
| Dec 31, 2023 | 13.33M | 3.61M | 37.13% |
| Dec 31, 2022 | 9.72M | 2.95M | 43.49% |
| Dec 31, 2021 | 6.77M | 1.04M | 18.16% |
| Dec 31, 2020 | 5.73M | -262.81K | -4.38% |
| Dec 31, 2019 | 5.99M | 2.47M | 70.06% |
| Dec 31, 2018 | 3.52M | -617.93K | -14.92% |
| Dec 31, 2017 | 4.14M | 2.72M | 190.26% |
| Dec 31, 2016 | 1.43M | -942.51K | -39.77% |
| Dec 31, 2015 | 2.37M | 625.36K | 35.85% |
| Dec 31, 2014 | 1.74M | -1.08B | -99.84% |
| Dec 31, 2013 | 1.09B | 1.08B | 90,005.99% |
| Dec 31, 2012 | 1.20M | -675.67K | -35.93% |
| Dec 31, 2011 | 1.88M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sanofi | 48.92B |
| EssilorLuxottica Société anonyme | 29.29B |
| Ipsen | 4.29B |
| Sartorius Stedim Biotech | 3.01B |
| Guerbet | 798.67M |
| Euroapi | 794.60M |
| Eurofins-Cerep | 41.10M |
| ABIONYX Pharma | 4.06M |